SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) — Capricor Therapeutics CAPR, a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, today announced the appointment of Philip J. Gotwals, Ph.D., to its Board of Directors, effective…Read More
Capricor Therapeutics Announces Appointment of Philip J Gotwals PhD to its Board of Directors Capricor Therapeutics NASDAQCAPR
